Lifestyle Medicine 2026

Measure • Restore • Verify

Lifestyle Medicine 2026 (LM2026) · American College of Lifestyle Medicine · Orlando, Florida, November 8–11, 2026Show your patients it worked

Lifestyle medicine changes behaviour, then has to prove it. At LM2026 a partner presents our research, and our poster alongside it shows how a five-minute microvascular measurement fits that practice.

November 8–11, 2026 Orlando, Florida Research poster
Our poster Conference registration

Our poster at Lifestyle Medicine 2026

Integrating Microvascular Glycocalyx Assessment into Lifestyle Medicine

  • Donald McGee, MD, PhD, FAAFP, ABEM (retired)
  • Hans Vink, PhD · Chief Science Officer, Glycocalyx Research Institute
  • Robert M. Long · Chief Executive Officer, Glycocalyx Research Institute

At Lifestyle Medicine 2026 a partner presents our research paper, and this poster sits nearby for anyone who wants to know more: about the glycocalyx, about GlycoCheck™, and about the Institute. Scan either code on the poster, or start here.

The poster in full Read the six-year study

What the poster shows

  • Traditional cardiovascular risk models often miss early microvascular dysfunction.
  • A clinical practice model that brings non-invasive glycocalyx assessment into lifestyle medicine’s six pillars.
  • Sublingual imaging with GlycoCheck™ measures glycocalyx integrity as PBR, inside a workflow of risk assessment, measurement, patient education and an individual plan.
  • Patients otherwise rated low or intermediate risk are identified, and seeing their own vessels improves engagement and adherence.
  • Repeat measurement follows each patient’s response to treatment over time.

Want to be measured? Find a GlycoCheck™ test location. New to the Institute? The six pillars, at the capillary level.

Our clinical workflow

Measure • Restore • Verify

Three steps that turn vascular health from something you infer into something you can show a patient.

M

Measure

Use the GlycoCheck™ System to objectively assess endothelial glycocalyx and microvascular health through a simple, non-invasive assessment performed under the tongue in under 5 minutes.

R

Restore

Develop personalised treatment strategies using ReVasca™, lifestyle medicine, nutrition, exercise and risk-factor reduction.

V

Verify

Repeat GlycoCheck™ assessments to objectively measure patient improvement, guide clinical decisions and document treatment effectiveness over time.

250+Academic research centres worldwide
80+US medical clinic locations and growing
280+Published works
20+Years of research

The science

The endothelial glycocalyx: the foundation of vascular health

The glycocalyx is the fragile gel layer lining every blood vessel in your body. When it degrades, delivery fails in the microvessels first — long before a standard test finds anything. GlycoCheck images that layer directly and scores it.

Read the research
Illustration comparing a healthy endothelial glycocalyx with a compromised one
Healthy versus compromised endothelial glycocalyx.
Capillary imaging before and after 12 weeks, showing Microvascular Health Score rising
Microvascular Health Score before, and after 12 weeks taking ReVasca™. Individual results vary.

Verify

Objective outcomes, not impressions

Re-testing is the point. A repeat GlycoCheck assessment shows whether an intervention moved the patient’s microvasculature — so you can guide clinical decisions, document effectiveness and show the patient their own progress.

  • Repeat assessments on the same objective scale
  • Guide clinical decisions with data
  • Document treatment effectiveness over time

The conference

About Lifestyle Medicine 2026

LM2026 is the American College of Lifestyle Medicine’s annual conference, themed “Health Restoration and Care Transformation” and built around chronic-disease root causes, remission as a clinical goal, and de-escalating medication. In-person attendance is capped at 2,300 and historically sells out, with a further virtual audience on top.

The programme runs fifteen plenaries and twenty-four concurrent sessions across four tracks, plus a research row of more than two hundred abstracts. Lifestyle medicine’s own definition names cardiovascular disease, type 2 diabetes and obesity first — the exact territory the microvasculature sits in.

Who attends: Physicians, physician associates and nurse practitioners, nurses, pharmacists, registered dietitians, exercise physiologists, health coaches, researchers and health-system executives.

Organiser: American College of Lifestyle Medicine
Venue: Rosen Shingle Creek Resort
Dates: November 8–11, 2026

Register at lifestylemedicine.org

Why we are there

  • Lifestyle medicine changes behaviour and then needs to show it worked. Microvascular health responds to exactly the levers this audience already pulls.
  • We lead with measurement and the published research, not the supplement, because it is the stronger argument for this audience.
  • A partner presents our research, and our poster nearby sets out a practice model that puts glycocalyx assessment alongside the six pillars of lifestyle medicine.

Before you come

Frequently asked

When and where is Lifestyle Medicine 2026?
LM2026, the American College of Lifestyle Medicine’s annual conference, runs November 8–11, 2026 at the Rosen Shingle Creek Resort, 9939 Universal Boulevard, Orlando, Florida 32819, with pre-conference workshops beginning on the Saturday and a full online option. Registration is at lifestylemedicine.org.
Is there CME or CE credit?
ACLM accredits the conference across multiple disciplines and expects LM2026 credit totals to be comparable to previous years. Check the current figure for your own profession with ACLM when you register.
How can I get a GlycoCheck™ reading or see a demonstration?
Clinics across the US offer a reading: find a GlycoCheck test location near you. To see the system for your own practice, request a demonstration and we will arrange it.
Where can I read more about the poster?
The poster page summarises it, explains the measurement and links to the six-year study it draws on: Ikonomidis et al., Journal of Cardiovascular Translational Research, 2021.
What is GlycoCheck™?
GlycoCheck is a non-invasive imaging system that measures the endothelial glycocalyx and microvascular health directly, under the tongue, in under five minutes. It produces an objective Microvascular Health Score rather than an estimate from a questionnaire.
Does it hurt, and is it invasive?
No. It is entirely non-invasive — a small camera images the capillaries under your tongue. There are no needles and no blood draw.
What is ReVasca™?
ReVasca is our endothelial glycocalyx support formula* — the “restore” step after measurement. You can read the full formulation and the research behind it on the ReVasca product page.
How do I bring GlycoCheck™ into my practice?
Start at our practitioner information page. We can walk through implementation, training and what a clinic workflow looks like.
Where can I find the published research?
Our research library holds the peer-reviewed work on the glycocalyx, microvascular health and the methodology behind GlycoCheck.

Also this autumn

Where else to find us

Oct 2–4 AAMP Fall Conference 2026 Scottsdale, Arizona Oct 7–11 Translational Longevity Summit 2026 Boston, Massachusetts Nov 5–7 Frontiers 10 Ozone Conference Santa Barbara, California

All conferences and events

Measure • Restore • Verify

Find our poster at Lifestyle Medicine 2026

It sits alongside our partner’s presentation of the research, and everything on it is here online too.

Read about the poster Request a GlycoCheck demonstration See all our events

* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.